iRhythm Technologies, Inc. (IRTC)

NASDAQ: IRTC · IEX Real-Time Price · USD
121.21
+1.98 (1.66%)
Mar 24, 2023, 4:00 PM EDT - Market closed
1.66%
Market Cap 3.66B
Revenue (ttm) 410.92M
Net Income (ttm) -116.16M
Shares Out 30.22M
EPS (ttm) -3.88
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 261,659
Open 118.64
Previous Close 119.23
Day's Range 117.57 - 121.55
52-Week Range 85.74 - 169.54
Beta 1.41
Analysts Buy
Price Target 144.97 (+19.6%)
Earnings Date May 4, 2023

About IRTC

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and E... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Oct 20, 2016
Employees 1,700
Stock Exchange NASDAQ
Ticker Symbol IRTC
Full Company Profile

Financial Performance

In 2022, IRTC's revenue was $410.92 million, an increase of 27.29% compared to the previous year's $322.83 million. Losses were -$116.16 million, 14.6% more than in 2021.

Financial Statements

Analyst Forecast

According to 17 analysts, the average rating for IRTC stock is "Buy." The 12-month stock price forecast is $144.97, which is an increase of 19.60% from the latest price.

Price Target
$144.97
(19.60% upside)
Analyst Consensus: Buy
Stock Forecasts

News

iRhythm Technologies (IRTC) Soars 3.9%: Is Further Upside Left in the Stock?

iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength...

1 week ago - Zacks Investment Research

10 Companies That Had Tons of Money in SVB When It Collapsed

Since SVB Financial's (NASDAQ: SIVB) principal subsidiary, Silicon Valley Bank, collapsed last week, Wall Street has been in turmoil. With SVB seized by government regulators and New York's Signature...

1 week ago - InvestorPlace

4 Stocks With Huge Cash Holdings at Silicon Valley Bank

We're witnessing the second-largest bank failure in United States history as regulators shut down Silicon Valley Bank (NASDAQ: SIVB). Nobody has any idea what the implications are.

Other symbols: ATYONCRROKU
1 week ago - MarketBeat

Large Real-World Evidence Analysis Demonstrates that Zio® XT Is Associated With the Highest Diagnostic Yield, Lowest Retesting Rates, and Fastest Time to Clinical Diagnosis Compared to Other Ambulatory ECG Monitors

Additional studies presented at ACC.23/WCC reinforce the clinical value of the Zio suite of products and services Additional studies presented at ACC.23/WCC reinforce the clinical value of the Zio sui...

2 weeks ago - GlobeNewsWire

Four New Studies Featuring Zio® by iRhythm to be Presented at ACC.23/WCC

iRhythm continues to expand its strong body of clinical and scientific evidence with new research presented by leading clinical investigators at the conference

3 weeks ago - GlobeNewsWire

iRhythm Technologies Announces Fourth Quarter and Full Year 2022 Financial Results

SAN FRANCISCO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preven...

1 month ago - GlobeNewsWire

iRhythm Technologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

SAN FRANCISCO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict...

1 month ago - GlobeNewsWire

iRhythm Technologies Shares Preliminary Fourth Quarter 2022 Highlights and Business Update at the 41st Annual J.P. Morgan Healthcare Conference

SAN FRANCISCO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent...

2 months ago - GlobeNewsWire

iRhythm® Technologies to Present at the 41st Annual J.P. Morgan Healthcare Conference

SAN FRANCISCO, Dec. 27, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent...

3 months ago - GlobeNewsWire

Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm's Product Portfolio Presented at American Heart Association '22

Clinical studies presented at the American Heart Association 2022 Scientific Sessions event demonstrate compelling diagnostic and health economic value of the Zio® suite of products across a range of ...

4 months ago - GlobeNewsWire

New Research Confirms that Zio® by iRhythm Provides High Value From a Health Economic Perspective

A new analysis of iRhythm's mSToPS trial, presented at the American Heart Association, reveals that Zio® XT provided high value from a health economic perspective A new analysis of iRhythm's mSToPS tr...

4 months ago - GlobeNewsWire

iRhythm® Technologies Comments on the Final Medicare Physician Fee Schedule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023

SAN FRANCISCO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict...

5 months ago - GlobeNewsWire

iRhythm® Technologies Comments on the Announcement of the Medicare Physician Fee Schedule Final Rule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023

SAN FRANCISCO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict...

5 months ago - GlobeNewsWire

IRhythm Technologies (IRTC) Reports Q3 Loss, Misses Revenue Estimates

iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 23.17% and 2.40%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock...

5 months ago - Zacks Investment Research

iRhythm Technologies Announces Third Quarter 2022 Financial Results

SAN FRANCISCO, Nov. 01, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predic...

5 months ago - GlobeNewsWire

7 Robotic Stocks to Buy for the Coming Robot Boom

The robotics industry has been growing at an incredible pace, and the computing power needed for these mechatronic devices is getting cheaper by the day. The increased computing power and data handlin...

Other symbols: IPGPISRGNVDAPATHTER
5 months ago - InvestorPlace

7 Momentum Stocks to Buy Now for Extraordinary Gains

Before jumping directly into momentum stocks worth buying now, it's important to understand what momentum trading is. As the name implies, momentum trading relies on reacting to the current movement o...

6 months ago - InvestorPlace

iRhythm Technologies Details Growth Strategies at 2022 Analyst & Investor Day

SAN FRANCISCO, Sept. 21, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent and predic...

6 months ago - GlobeNewsWire

iRhythm Technologies to Host Analyst & Investor Day on September 21, 2022

SAN FRANCISCO, Aug. 31, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced ...

7 months ago - GlobeNewsWire

IRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates

iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 15.96% and 2.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

iRhythm Technologies to Present at the Canaccord Genuity 42nd Annual Growth Conference

SAN FRANCISCO, July 28, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced th...

8 months ago - GlobeNewsWire

Analysts Estimate iRhythm Technologies (IRTC) to Report a Decline in Earnings: What to Look Out for

IRhythm Technologies (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

8 months ago - Zacks Investment Research

iRhythm Technologies Announces the Addition of Two Executive Leaders to Advance Strategic Growth and Operational Excellence

SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced th...

8 months ago - GlobeNewsWire

iRhythm Gains FDA Clearance for its Clinically Integrated ZEUS System

Developed in partnership with Verily, the Zio® Watch and the ZEUS System combine to create a clinical grade watch to detect and characterize AFib and integrate with clinician's workflow Developed in p...

8 months ago - GlobeNewsWire

iRhythm Technologies Announces Chief Commercial Officer Transition and Schedules Second Quarter Earnings Release and Conference Call for August 4, 2022

SAN FRANCISCO, July 18, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced th...

8 months ago - GlobeNewsWire